However, this composite score did not change significantly in the L-Carnitine group ( P = 0.232), and decreased slightly in the placebo group ( P = 0.534)
Covered does not automatically mean easy to access, Dr
Looking to up your wellness game this year
SOUL was a randomized, double blind, parallel-group, placebo-controlled superiority trial that enrolled 9,650 adults with T2DM who had established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or both, to receive a maximum daily dose of 14 mg oral semaglutide or placebo
Slow dose escalation improves tolerance and minimizes the potential risks
Thats why microdosing gets so much attention